← Back to Search

Guided Meditation Intervention for Brain Tumor (Med-RT Trial)

N/A
Recruiting
Led By Lindsay Burt, MD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant aged ≥ 18 years
Eligible to undergo radiation treatment for brain tumor for 25-33 treatments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 weeks
Awards & highlights

Med-RT Trial Summary

This trial investigates whether guided meditation during radiation treatment can reduce anxiety in patients with brain tumors.

Who is the study for?
This trial is for adults over 18 with brain tumors who are set to undergo 25-33 radiation treatments. They must have a certain level of physical and cognitive ability, be willing to try guided meditation or just standard care, and able to consent. People with suicidal thoughts, psychosis, unstable illnesses that could affect treatment, previous brain radiation therapy, or those not fluent in English can't join.Check my eligibility
What is being tested?
The study tests if a short guided meditation played during each radiation session can reduce anxiety more than the usual care without any intervention. Participants will either receive this mindfulness practice or follow the standard procedure as they go through their scheduled treatments.See study design
What are the potential side effects?
Since the intervention involves only audio-guided meditation practices and no medication or invasive procedures, there are minimal expected side effects. However, individual reactions to relaxation techniques may vary.

Med-RT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am approved for 25-33 radiation treatments for my brain tumor.
Select...
I have a brain tumor confirmed by imaging tests.
Select...
I can care for myself but may not be able to do active work.

Med-RT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in acute anxiety, measured by score on individual item derived from GAD-2, in participants receiving mindfulness intervention during RT compared to standard of care control conditions.
Secondary outcome measures
Change in anxiety during RT and in everyday life as measured by the modified MPoD
Change in anxiety in everyday life in participants receiving mindfulness intervention during RT compared to standard of care, measured using the total score of the GAD-2 scale prior to RT
Change in self transcendence and the magnitude/degree of change in self transcendence as measured by total score of the Nondual Awareness Dimensional Assessment (NADA.)

Med-RT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Guided Meditation InterventionExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,100 Previous Clinical Trials
1,778,871 Total Patients Enrolled
Lindsay Burt, MDPrincipal InvestigatorHuntsman Cancer Institute/ University of Utah
1 Previous Clinical Trials
68 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research program currently seeking participants?

"Clinicaltrials.gov shows that the recruitment for this medical trial has been concluded, as it was last updated on December 8th 2023. However, 412 other studies are still recruiting participants at present."

Answered by AI
~20 spots leftby Jan 2026